Finding the 340B Balance: Threat or Opportunity? (Expanding Opportunities)

Saturday, October 14, 2017
4:45 - 5:45 p.m.
5:45 - 6:15 p.m. * Special Shoot the Breeze Sharing Session to Follow* (Non-CE)
Gaylord Palms Resort & Convention Center, Orlando, Fla.
ACPE UAN: 0207-0000-17-214-L04-P and 0207-0000-17-214-L04-T
1.0 contact hours (0.1 CEUs)

340B: what is good and what is bad, and is it a threat or an opportunity for your business? There are several potential legislative and regulatory changes that could impact the 340B program for pharmacy, hospitals, pharma, payers, and the government, but what do these potential changes mean for you? Could they bring more opportunity? Or, could it enable 340B to be a bigger threat to your business and patients? You’ve got questions, we’ve got answers! This session gives you multiple viewpoints and helps you evaluate what 340B could mean for your pharmacy.

Pharmacist and Pharmacy Technician Learning Objectives:

  1. Discuss the current political environment in Washington surrounding the 340B program.

  2. Summarize the results of a recent study that shows the importance of contract pharmacy to 340B hospitals and their patients.

  3. Describe the flow of patients and product through the 340B system.

Speakers: Greg Doggett, 340B Health, Washington, D.C.; Amanda Gaddy, RPh, Co-Founder, Secure340B, McDonough, Ga.; Jeff Malone, President/CEO, RxPreferred Benefits, Mt. Juliet, Tenn.; Susan Pilch, Vice President Policy and Regulatory Affairs, NCPA, Alexandria, Va.

Activity Type: Application-based
Audience: Pharmacists and Pharmacy Technicians